trandolapril and verapamil hydrochloride
Generic: trandolapril and verapamil hydrochloride
Labeler: glenmark pharmaceuticals inc., usaDrug Facts
Product Profile
Brand Name
trandolapril and verapamil hydrochloride
Generic Name
trandolapril and verapamil hydrochloride
Labeler
glenmark pharmaceuticals inc., usa
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
Active Ingredients
trandolapril 4 mg/1, verapamil hydrochloride 240 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68462-329
Product ID
68462-329_770b4914-a475-4841-83f8-79261f115eff
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA079135
Listing Expiration
2027-12-31
Marketing Start
2015-02-25
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68462329
Hyphenated Format
68462-329
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
trandolapril and verapamil hydrochloride (source: ndc)
Generic Name
trandolapril and verapamil hydrochloride (source: ndc)
Application Number
ANDA079135 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/1
- 240 mg/1
Packaging
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-01)
- 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-10)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "770b4914-a475-4841-83f8-79261f115eff", "openfda": {"nui": ["N0000175562", "N0000000181"], "upc": ["0368462294017", "0368462329016"], "unii": ["V3888OEY5R", "1T0N3G9CRC"], "rxcui": ["897781", "897783", "897844", "897853"], "spl_set_id": ["39bad727-af4c-4d20-933b-7f287e88099a"], "pharm_class_epc": ["Angiotensin Converting Enzyme Inhibitor [EPC]"], "pharm_class_moa": ["Angiotensin-converting Enzyme Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-01)", "package_ndc": "68462-329-01", "marketing_start_date": "20150225"}, {"sample": false, "description": "1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-10)", "package_ndc": "68462-329-10", "marketing_start_date": "20150225"}], "brand_name": "Trandolapril and Verapamil Hydrochloride", "product_id": "68462-329_770b4914-a475-4841-83f8-79261f115eff", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68462-329", "generic_name": "Trandolapril and Verapamil Hydrochloride", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trandolapril and Verapamil Hydrochloride", "active_ingredients": [{"name": "TRANDOLAPRIL", "strength": "4 mg/1"}, {"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA079135", "marketing_category": "ANDA", "marketing_start_date": "20150225", "listing_expiration_date": "20271231"}